Novadaq Technologies
Novadaq Technologies developed fluorescence imaging systems (SPY Elite, SPY PHI) for real-time intraoperative visualization of tissue perfusion and blood flow, serving hospitals and surgical centers. Acquired by Stryker in 2017 for $700M.
- Company typePrivate
- Founded2000
- HeadquartersKalamazoo, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Novadaq Technologies does
Novadaq Technologies was a medical technology company headquartered in Kalamazoo, Michigan, that developed fluorescence imaging systems for surgical applications. The company's core technology enabled real-time intraoperative visualization of tissue perfusion and blood flow, allowing surgeons performing minimally invasive procedures to assess tissue viability during operations. Its principal commercial products included the SPY Elite and SPY PHI Fluorescence Imaging Systems, which were sold to hospitals and surgical centers as capital equipment integrated into operating room workflows.
The company operated a horizontal go-to-market targeting medical facilities and healthcare providers, with sales driven by clinical adoption among surgical specialties. Novadaq expanded its platform through M&A, acquiring Xillix in 2007 and Aïmago in 2014 for $12.4 million, broadening its fluorescence imaging capabilities. The company reached commercial-stage status and was publicly traded on NASDAQ under ticker NVDQ before being acquired by Stryker Corporation in 2017 for $700 million. Following the acquisition, Novadaq's technology was integrated into Stryker's Endoscopy business unit within its surgical visualization portfolio, and the company ceased operating as an independent entity.
Novadaq Technologies firmographics
Firmographics- Name
- Novadaq Technologies
- Legal name
- Novadaq Technologies
- Website
- https://novadaq.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Acquired
- Headcount range
- 501–1,000 employees
- Short description
- Novadaq Technologies developed fluorescence imaging systems (SPY Elite, SPY PHI) for real-time intraoperative visualization of tissue perfusion and blood flow, serving hospitals and surgical centers. Acquired by Stryker in 2017 for $700M.
- Ownership category
- akta.pro rank
Novadaq Technologies industry classification
Industry- Product category
- Surgical Visualization & Fluorescence Imaging
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Optical Instruments & Lenses (3827)
- akta.pro primary industry
- Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH)
- akta.pro secondary industries
- Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing) (HLAHADAD), Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB), Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)
Keywords
Where Novadaq Technologies is headquartered
LocationHeadquarters
- HQ city
- Kalamazoo
- HQ country
- United States
- HQ region
- North America
Markets served
Novadaq Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain
Novadaq Technologies product offering
Product offeringCore offering
Novadaq Technologies developed and commercialized clinically-relevant fluorescence imaging solutions — including the SPY Elite and SPY PHI systems — that enabled surgeons to visualize tissue perfusion, blood flow, and tissue viability in real time during open and minimally invasive procedures in the operating room and clinic. The company also performed tuck-in acquisitions of complementary imaging businesses (Xillix in 2007, Aïmago in 2014).
Product overview
Novadaq Technologies was a privately held medical technology company specializing in fluorescence imaging technology for surgical applications. The company was acquired by Stryker Corporation in 2017 for $700 million. Following the acquisition, Novadaq's technology became part of Stryker's surgical visualization portfolio. The source data does not contain first-party Novadaq product documentation or website content from which specific product details could be extracted.
Differentiator
Problem solved
Functional benefit
Products and services
- SPY Elite Fluorescence Imaging System Fluorescence imaging platform that enables surgeons to visualize tissue perfusion and blood flow in real time during open and minimally invasive surgical procedures in the operating room.
- SPY PHI Fluorescence Imaging System Companion fluorescence imaging system to SPY Elite, providing intraoperative visualization of perfusion and tissue viability for surgical applications across the operating room and clinic.
Quantifiable outcome
- Achieved commercial-stage exit valued at $700 million
Companies that use Novadaq Technologies
Customer profileSegments1 record
Ideal customer profiles1 record
Novadaq Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Novadaq Technologies partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- StrykermajorStryker Corporation acquired Novadaq Technologies for $700 million in 2017. This commercial-stage acquisition was cited as an example of successful medtech exits, significantly outperforming pre-commercial exits. The acquisition expanded Stryker's surgical visualization portfolio.
Scale indicators1 record
Recent moves4 records
Expansion highlights3 records
Novadaq Technologies competitors and assessment
Company assessmentDirect peers
- Intuitive Surgical: Da Vinci platform with Firefly fluorescence imaging integrates ICG-based intraoperative visualization into robotic surgery — the most direct modality competitor to Novadaq's SPY in minimally invasive procedures.
- Karl Storz: Endoscopy and surgical visualization incumbent offering ICG/near-infrared fluorescence imaging modules (e.g., IMAGE1 S, NIR/ICG modes) that compete head-to-head with SPY in laparoscopic and open surgery.
- Olympus: Major surgical visualization platform (VISERA, ORBEYE 4K 3D) with NBI and IR fluorescence imaging options, competing for the same intraoperative visualization use cases that SPY addresses.
- Carl Zeiss Meditec: Surgical microscopy and visualization (e.g., OPMI Pentero, Kinevo) used in neurosurgery, ENT, and ophthalmology; provides intraoperative optical imaging capabilities overlapping with SPY's clinical role.
- Leica Microsystems (Danaher): Surgical microscopy platform (e.g., M530 OHX, ARveo) with fluorescence imaging modes for neurosurgical and intraoperative use — direct overlap with Novadaq's fluorescence-guided surgery niche.
Broad incumbents
- Medtronic: Diversified medtech incumbent with surgical visualization and imaging offerings (e.g., StealthStation, surgical endoscopy) that compete for OR capital and procedure-utility share against SPY.
- Getinge (Maquet): OR integration and surgical equipment provider (lights, tables, surgical workplace) competing in the integrated OR where SPY-class visualization systems are installed and sold.
- Stryker: Acquirer of Novadaq and the parent company that now owns and distributes the SPY platform as part of its surgical visualization and endoscopy portfolio. Directly comparable as the strategic home for Novadaq's technology.
Emerging players
- Hamamatsu Photonics: Developer of optoelectronic imaging components and ICG-compatible camera/sensor technology used in fluorescence imaging systems — comparable as an enabling/adjacent technology supplier to SPY-class platforms.
- Conmed: General surgery and visualization portfolio (airSeal, hand instruments) that overlaps with the broader surgical visualization workflow where SPY is deployed in laparoscopic and robotic procedures.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Novadaq Technologies social profiles
Digital presenceNovadaq Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Novadaq Technologies leadership team
Management profileNumber of profiles
Novadaq Technologies funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Novadaq Technologies M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Novadaq Technologies
What does Novadaq Technologies do?
Novadaq Technologies developed and commercialized clinically-relevant fluorescence imaging solutions — including the SPY Elite and SPY PHI systems — that enabled surgeons to visualize tissue perfusion, blood flow, and tissue viability in real time during open and minimally invasive procedures in the operating room and clinic. The company also performed tuck-in acquisitions of complementary imaging businesses (Xillix in 2007, Aïmago in 2014).
Is Novadaq Technologies a public or private company?
Novadaq Technologies is a private company. It is classified as corporate owned and is currently acquired.
When was Novadaq Technologies founded?
Novadaq Technologies was founded in 2000. It employs 501 to 1,000 people.
Where is Novadaq Technologies based?
Novadaq Technologies is headquartered in Kalamazoo, United States, in the North America region.
Who are Novadaq Technologies's main competitors?
Direct peers on record are Intuitive Surgical, Karl Storz, Olympus, Carl Zeiss Meditec and Leica Microsystems (Danaher). Broad incumbents are Medtronic, Getinge (Maquet) and Stryker. Emerging players are Hamamatsu Photonics and Conmed.
Does Novadaq Technologies have an API?
No public API is recorded for Novadaq Technologies.
What industry is Novadaq Technologies in?
Novadaq Technologies's product category is Surgical Visualization & Fluorescence Imaging. Its primary akta.pro industry code is HLAHADAH, Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence), with a secondary code of HLAHADAD, Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing). Its NAICS code is 339112 and its SIC code is 3841.